Vascular rejection with tacrolimus and potential long-term graft outcome
- PMID: 10576054
- DOI: 10.1016/s0041-1345(99)00805-2
Vascular rejection with tacrolimus and potential long-term graft outcome
Similar articles
-
Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?Transplant Rev (Orlando). 2009 Jan;23(1):47-52. doi: 10.1016/j.trre.2008.08.005. Transplant Rev (Orlando). 2009. PMID: 19027616 Review.
-
Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy.Transplant Proc. 1996 Dec;28(6):3165. Transplant Proc. 1996. PMID: 8962226 No abstract available.
-
Conversion to tacrolimus immunosuppression in renal transplant recipients: 12-month follow-up.Transplant Proc. 2002 Aug;34(5):1685-6. doi: 10.1016/s0041-1345(02)02982-2. Transplant Proc. 2002. PMID: 12176535 No abstract available.
-
Acute rejection and the therapeutic choice of drug.Transplant Proc. 2000 Nov;32(7):1759-60. doi: 10.1016/s0041-1345(00)01387-7. Transplant Proc. 2000. PMID: 11119923 No abstract available.
-
Tacrolimus in pediatric renal transplantation: a review.Pediatr Transplant. 1998 Nov;2(4):270-6. Pediatr Transplant. 1998. PMID: 10084728 Review.
Cited by
-
The impact of inherited thrombophilia on surgery: a factor to consider before transplantation?Mol Biol Rep. 2009 May;36(5):1041-51. doi: 10.1007/s11033-008-9278-4. Epub 2008 May 31. Mol Biol Rep. 2009. PMID: 18516702 Review.
-
Immunosuppression for long-term maintenance of renal allograft function.Drugs. 2004;64(12):1325-38. doi: 10.2165/00003495-200464120-00005. Drugs. 2004. PMID: 15200347 Review.
-
Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.Drugs. 2000 Feb;59(2):323-89. doi: 10.2165/00003495-200059020-00021. Drugs. 2000. PMID: 10730553
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical